Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab TreatmentSatoshi Hirano,Nami Hayama,Hiroshi Tabeta,Tsuguko Kuroki,Yuka Shiraishi,Tetsuo Fujita,Hiroyuki Amano,Makoto Nakamura,Shinichiro Shimizu,Sukeyuki NakamuraJournal of Thoracic Oncology(2020)引用 5|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要